A single dose of the vaccine reduces the risk of hospital admission by more than 90 per cent and the Oxford jab is slightly more effective at this than the Pfizer one, new evidence suggests. Results from a large English trial due to be published this month show that the vaccine developed by Oxford University and AstraZeneca is highly effective at preventing people from becoming seriously ill from Covid-19. Even people over the age of 70 are much less likely to need hospital treatment after one dose, the analysis shows. SponsoredSimilar results were seen with the vaccine developed by Pfizer-BioNTech, although they were slightly less robust. Public health officials calculated the latest efficacy figures by comparing Covid hospital admission rates across England in those

Source: The Times March 01, 2021 00:05 UTC